Novakowski, Stefanie K
Kabajaasi, Olive
Kinshella, Mai-Lei Woo
Pillay, Yashodani
Johnson, Teresa
Dunsmuir, Dustin
Pallot, Katija
Rigg, Jessica
Kenya-Mugisha, Nathan
Opar, Bernard Toliva
Ansermino, J Mark
Tagoola, Abner
Kissoon, Niranjan
Funding for this research was provided by:
Grand Challenges Canada (2008-35944, 2008-35944, 2008-35944, 2008-35944, 2008-35944, 2008-35944, 2008-35944, 2008-35944, 2008-35944, 2008-35944, 2008-35944)
Wellcome Trust (215695/B/19/Z, 215695/B/19/Z, 215695/B/19/Z, 215695/B/19/Z, 215695/B/19/Z, 215695/B/19/Z, 215695/B/19/Z)
Article History
Received: 9 June 2022
Accepted: 20 September 2022
First Online: 13 October 2022
Declarations
:
: Ethics approvals for the parent clinical trial and this sub-study were obtained from the Makerere University School of Public Health Higher Degrees Research and Ethics Committee (IRB00011353, Study Protocol Number 743), Uganda National Council for Science and Technology (ID: HS528ES), and Children’s and Women’s Health Centre of British Columbia Research Ethics Board (H2-20-00484). All methods were performed in accordance with the relevant guidelines and regulations. Written informed consent was obtained from all participants.
: Not applicable.
: The authors declare they have no competing interests.